In the fourth episode of the series Dr Sarah Welsh and Mr Tom Mitchell talk about their translational research and how it has helped to determine cancer genetics in renal cancer.
May 25, 2022
In the fourth episode of the series Dr Sarah Welsh and Mr Tom Mitchell talk about their translational research and how it has helped to determine cancer genetics in renal cancer.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
